Point72 Asset Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
|
|||||
|
2025
Q1 | $1.68M | Hold |
|
|||||
|
2024
Q4 | $2.73M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $5.03M | Sell |
|
|||||
|
2022
Q1 | $11.7M | Sell |
|
|||||
|
2021
Q4 | $27.3M | Hold |
|
|||||
|
2021
Q3 | $32.1M | Sell |
|
|||||
|
2021
Q2 | $40.5M | Buy |
|
|||||
|
2021
Q1 | $49M | Buy |
|
|||||
|
2020
Q4 | $819K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $8.61M | Buy |
|
|||||
|
2020
Q1 | $1.66M | Sell |
|
|||||
|
2019
Q4 | $5.99M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $3.71M | Sell |
|
|||||
|
2019
Q1 | $6.73M | Sell |
|
|||||
|
2018
Q4 | $22.1M | Buy |
|
|||||
|
2018
Q3 | $24.6M | Buy |
|
|||||
|
2018
Q2 | $3.62M | Buy |
|